Literature DB >> 8553538

Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.

M B Agy1, R L Acker, C H Sherbert, M G Katze.   

Abstract

We have examined the effects of interferon (IFN)-alpha/beta on HIV-1 and SIV replication in CD4+ T-cell lines. To enable us to examine these effects on a single cycle of virus replication, cells were synchronously infected with HIV-1 LAI or SIV mac251. Cell lines included MT4 cells which were responsive to IFN and, as controls, C8166 cells which failed to respond to interferon treatment. Similar to previous reports, we found that replication of both HIV-1 and SIV was markedly inhibited in responsive MT4 cell lines treated with IFN. No such decreases were observed in HIV-1-infected, IFN-treated C8166 cells. Levels of both intracellular and extracellular viral antigens decreased in both HIV-1- and SIV-infected MT4 cells treated with IFN. Whereas steady state levels of viral-specific RNAs dramatically declined in SIV-infected cells, no such decrease was observed in IFN-treated HIV-1-infected cells. In accordance with these data, the rate of viral protein synthesis did not significantly change in HIV-1-infected, IFN-treated MT-4 cells. Western blot analysis of extracts prepared from IFN-treated HIV-1-infected cells revealed a decreased accumulation of most HIV-1-specific glycoproteins and proteins with the exception of the pr55 gag precursor. Pulse-chase experiments confirmed the enhanced stability of pr55 in IFN-treated cells, but also unexpectedly demonstrated the accelerated and quantitative processing of the p26 precursor (p24 capsid [CA] plus p2) to the final processed p24 (CA) polypeptide. These data, taken together, suggest that IFN deregulated viral protein processing and caused reduced protein stability in HIV-1-infected cells while inhibiting an earlier stage of replication in SIV-infected cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8553538     DOI: 10.1006/viro.1995.0047

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR.

Authors:  M Benkirane; C Neuveut; R F Chun; S M Smith; C E Samuel; A Gatignol; K T Jeang
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

2.  Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.

Authors:  M O Hottiger; L K Felzien; G J Nabel
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

3.  The IFITM proteins inhibit HIV-1 infection.

Authors:  Jennifer Lu; Qinghua Pan; Liwei Rong; Wei He; Shan-Lu Liu; Chen Liang
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

4.  Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.

Authors:  Caroline Goujon; Michael H Malim
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

5.  Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.

Authors:  N Madani; D Kabat
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 7.  Human immunodeficiency virus, restriction factors, and interferon.

Authors:  Stuart Neil; Paul Bieniasz
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

8.  Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.

Authors:  Daniela Vendrame; Marion Sourisseau; Virginie Perrin; Olivier Schwartz; Fabrizio Mammano
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

9.  TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized Mice.

Authors:  Lee Adam Wheeler; Radiana T Trifonova; Vladimir Vrbanac; Natasha S Barteneva; Xing Liu; Brooke Bollman; Lauren Onofrey; Sachin Mulik; Shahin Ranjbar; Andrew D Luster; Andrew M Tager; Judy Lieberman
Journal:  Cell Rep       Date:  2016-05-12       Impact factor: 9.423

10.  A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Weiming Wang; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.